Renewed interest in psychedelics as treatments for mental disorders has recently emerged, but substantial challenges remain in obtaining evidence from available data to inform clinical decision-making. This Comment explores the current landscape of clinical psychedelic research, highlighting the need for a systematic approach to evidence synthesis.
- S. Parker Singleton
- Brooke L. Sevchik
- Theodore D. Satterthwaite
